{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:31:53Z","timestamp":1785461513203,"version":"3.56.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152557","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T18:41:05Z","timestamp":1460659265000},"page":"e0152557","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy"],"prefix":"10.1371","volume":"11","author":[{"given":"Kevin G.","family":"Buell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiysha","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Demontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adine","family":"Adonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Haddow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Dhasmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured cells of a patient with cutaneous T-cell lymphoma","volume":"77","author":"BJ Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Y Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological Aspects and World Distribution of HTLV-1 Infection","volume":"3","author":"A Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"ref4","unstructured":"European Centre for Disease Prevention and Control. (2015) Geographical distribution of areas with a high prevalence of HTLV-1 infection."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"ii","author":"A Gessain","year":"1985","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"M Osame","year":"1986","journal-title":"Lancet"},{"key":"ref7","first-page":"1096","article-title":"The risk of development of HTLV-I associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I","volume":"3","author":"JE Kaplan","year":"1990","journal-title":"J Aquir Immun Defic Synd"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","article-title":"Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad","volume":"17","author":"EM Maloney","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II infected blood donors. The REDS investigators","volume":"48","author":"EL Murphy","year":"1997","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/civ229","article-title":"Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis: A Longitudinal Cohort Study","volume":"61","author":"D Tanajura","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"M Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"ref12","first-page":"1003","article-title":"Infiltration of helper\/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection","volume":"140","author":"Y Iwasaki","year":"1992","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","article-title":"Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"52","author":"F Umehara","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","article-title":"High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"99","author":"PK Goon","year":"2002","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.77.17.9716-9722.2003","article-title":"High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4+ T Cells in Patients with HTLV-1-Associated Neurological Disease","volume":"77","author":"PKC Goon","year":"2003","journal-title":"The Journal of Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/viro.1996.0101","article-title":"High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis","volume":"217","author":"S Daenke","year":"1996","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","article-title":"High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease","volume":"177","author":"I Elovaara","year":"1993","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1172\/JCI117532","article-title":"Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"94","author":"K Furukawa","year":"1994","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","article-title":"Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients","volume":"95","author":"TF Greten","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0404.1997.tb08156.x","article-title":"Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I","volume":"169","author":"P Hollsberg","year":"1997","journal-title":"Acta Neurol Scand Suppl"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for Diagnostic Criteria of Tropical Spastic Paraparesis\/HTLV-I-Associated Myelopathy (TSP\/HAM)","volume":"22","author":"CMD Castro-Costa","year":"2006","journal-title":"AIDS Research and Human Retroviruses"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.sc.3101919","article-title":"Disability and determinants of gait performance in tropical spastic paraparesis\/HTLV-I associated myelopathy (HAM\/TSP)","volume":"45","author":"AC Franzoi","year":"2007","journal-title":"Spinal Cord"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/jnnp.2009.191239","article-title":"A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK","volume":"81","author":"F Martin","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13550289509111010","article-title":"HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings","volume":"1","author":"M Nakagawa","year":"1995","journal-title":"J Neurovirol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","article-title":"Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study","volume":"63","author":"S Olindo","year":"2006","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1590\/S0004-282X2009000500016","article-title":"Pain in tropical spastic paraparesis\/HTLV-I associated myelopathy patients","volume":"67","author":"CM De Castro-Costa","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/423957","article-title":"Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis","volume":"39","author":"E Gotuzzo","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/AJP.0b013e3181f195d3","article-title":"Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP)","volume":"27","author":"EC Netto","year":"2011","journal-title":"Clin J Pain"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sc.2009.83","article-title":"Low-back pain in HTLV-I-associated myelopathy\/tropical spastic paraparesis: nociceptive or neuropathic?","volume":"48","author":"IR Tavares","year":"2010","journal-title":"Spinal Cord"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"S Izumo","year":"1996","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-3-63","article-title":"Zidovudine plus lamivudine in Human T-lymphotropic virus type I-associated myelopathy: a randomised trial","volume":"3","author":"GP Taylor","year":"2006","journal-title":"Retrovirology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1675","DOI":"10.1371\/journal.pntd.0001675","article-title":"Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"6","author":"F Martin","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/aid.1991.7.1031","article-title":"Tropical Spastic Paraparesis\/Htlv-1-Associated Myelopathy (Tsp\/Ham)\u2014Treatment with An Anabolic-Steroid Danazol","volume":"7","author":"WJ Harrington","year":"1991","journal-title":"AIDS Research and Human Retroviruses"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/jnnp.56.11.1213","article-title":"Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy","volume":"56","author":"A Kataoka","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1590\/S0004-282X1993000300005","article-title":"Intravenous methylprednisolone in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"51","author":"AQ Araujo","year":"1993","journal-title":"Arq Neuropsiquiatr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"2","author":"M Nakagawa","year":"1996","journal-title":"J Neurovirol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF00439243","article-title":"Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis","volume":"145","author":"EH Garin","year":"1986","journal-title":"Eur J Pediatr"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jnnp.50.5.511","article-title":"A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects","volume":"50","author":"NM Milligan","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.47.11.930","article-title":"Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone","volume":"47","author":"IA Williams","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"ref40","first-page":"382","article-title":"WHO diagnostic guidelines of HAM","volume":"49","year":"1989","journal-title":"Weekly Epidemiological Record"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/aid.2012.0132","article-title":"HTLV-1 viral load variability and long-term trends in asymptomatic carriers and in patients with HTLV-1-related diseases","volume":"29","author":"MA Demontis","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaad.2013.04.007","article-title":"Methylprednisolone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers","volume":"69","author":"K Hirahara","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1742-4690-11-S1-P31","article-title":"A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy","volume":"11","author":"F Martin","year":"2014","journal-title":"Retrovirology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood.V46.2.235.235","article-title":"The effect of Hydrocortisone on the kinetics of normal human lymphocytes","volume":"46","author":"AS Fauci","year":"1975","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI107914","article-title":"Alternate-day prednisone therapy and human lymphocyte subpopulations","volume":"55","author":"AS Fauci","year":"1975","journal-title":"J Clin Invest"},{"key":"ref46","first-page":"54","article-title":"Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function","volume":"24","author":"AS Fauci","year":"1976","journal-title":"Clin Exp Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/S1807-59322007000200015","article-title":"Urinary and sexual manifestations of patients infected by HTLV-I","volume":"62","author":"P Oliveira","year":"2007","journal-title":"Clinics (Sao Paulo)"},{"key":"ref48","first-page":"32","article-title":"Potentially treatable subacute forms of infection due to the HTLV-1","volume":"31","author":"FJ Carod-Artal","year":"2000","journal-title":"Rev Neurol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0004-282X1998000100020","article-title":"HTLV-I-associated myelopathy\/tropical spastic paraparesis: report of 2 cases diagnosed in Florianopolis, Santa Catarina, Brazil","volume":"56","author":"LC Coral","year":"1998","journal-title":"Arq Neuropsiquiatr"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0022-510X(91)90192-A","article-title":"Leukoencephalopathy in Htlv-I-Associated Myelopathy Tropical Spastic Paraparesis\u2014Mri Analysis and A 2 Year Follow-Up-Study After Corticosteroid-Therapy","volume":"106","author":"J Kira","year":"1991","journal-title":"Journal of the Neurological Sciences"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2008.01.004","article-title":"Corticosteroid therapy in TSP\/HAM patients: the results from a 10 years open cohort","volume":"269","author":"MG Croda","year":"2008","journal-title":"J Neurol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T18:08:53Z","timestamp":1600452533000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152557"}},"subtitle":[],"editor":[{"given":"Douglas F.","family":"Nixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152557","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]}}}